ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BOVNF Bioinvent International AB (PK)

4.70
0.00 (0.00%)
Feb 27 2024 - Closed
Delayed by 15 minutes

Bioinvent International AB (PK) Financial Summary

The current BOVNF market cap is 309.28M. The company's latest EPS is SEK -0.6459 and P/E is -7.28.

Year End December 30 2022 20182019202020212022
SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)
Total Revenue 38.55M93.74M147.37M19.38M326.13M
Operating Income -123.08M-137M-74.96M-278.17M-50.47M
Net Income -123.16M-138.63M-76.33M-278.44M-42.5M
Year End December 30 2022 20182019202020212022
SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)
Total Assets 120.4M226.11M802.64M1.45B1.71B
Total Liabilities 32.78M56.68M59.14M80.32M106.09M
Total Equity 87.62M169.44M743.5M1.37B1.61B

Cash Flow

Year End December 30 2022 20182019202020212022
SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)
Operating -141.39M-125.43M-62.62M-245.84M-41.23M
Investing -3.85M-3.84M-6.7M-467.54M-628.85M
Financing 80.33M214.39M644.62M894.87M273.49M
Market Cap 309.28M
Price to Earnings Ratio -7.28
Price to Sales Ratio 0.95
Price to Cash Ratio 0.6
Price to Book Ratio 0.19
Dividend Yield -

Share Statistics

Shares Outstanding 65.8M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 100.52 (98.95%)

Company Info

Company Name Bioinvent International AB (PK)
Address the gamma building
lund SE-223 70
Website https://www.bioinvent.com
Industry drugs-health r&d/testing labs (H8)

Your Recent History

Delayed Upgrade Clock